Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

Ligand Pharmaceuticals / Equity Bottom-Up

<ul><li>Ligand Pharmaceuticals holds a portfolio of revenue, royalty & milestone generating assets that have been vetted by its internal investment team.</li><li>Ligand considers individual biopharmaceutical products, platforms, companies & income streams in its opportunity set.</li><li>It targets late-stage and commercial income-producing assets when making investments.</li></ul>

Ligand Pharmaceuticals holds a portfolio of revenue, royalty & milestone generating assets that have been vetted by its internal investment team.Ligand considers individual biopharmaceutical products, platforms, companies & income streams in its opportunity set.It targets late-stage and commercial income-producing assets when making investments.

Ligand Pharmaceuticals

LGND: Getting In Tune with MedTech